Brief: Calithera Biosciences Inc - Awarded Up To $2.4 Million From Cystic Fibrosis Foundation To Support Clinical Development Of Arginase Inhibitor, Cb-280
Nov 2 (Reuters) - Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES INC - AWARDED UP TO $2.4 MILLION
FROM
CYSTIC FIBROSIS FOUNDATION TO SUPPORT CLINICAL DEVELOPMENT OF
ARGINASE INHIBITOR, CB-280
Source text for Eikon: ID:nGNX5wkSfk
Further company coverage: CALA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution